Top Articles

EAN supports the G7 Canada Brain Economy Summit, a global initiative uniting leaders to position brain health and brain skills as drivers of economic growth, resilience, and cross-sector innovation.

The Innovative Health Initiative (IHI) has just published draft topic texts for its upcoming Call 11, expected to launch officially in late June 2025.

The European Commission has released draft details for Horizon Europe’s 2025 Cluster 1 – Health calls, with official publication expected on 22 May 2025. These calls include several funding opportunities of high relevance to the neurology research community.

Watch a full recording of the latest European Brain Health Summit, held in Brussels on 19 March under the heading 'Brain Health for a Resilient Europe'.

EAN Website Editor, Letizia Leocani, talks to Raphael Wurm, lead author of the eanNews Paper of the Month for January 2025, 'Mood Alterations in the Prodromal Phase of Sporadic Creutzfeldt-Jakob Disease'

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for March 2025.

Neuroscientists, Professors Michelle Monje and Frank Winkler, have been awarded The Brain Prize 2025, the world’s largest award for outstanding contributions to neuroscience.

Dr Magdalini Krommyda, an EAN Ambassador of Neurology and Brain Health, shares Greece’s innovative initiatives aimed at enhancing brain health and preventing cognitive decline.

A new paper published in Nature Reviews Neurology offers a cogent overview of patient involvement in medicine in the context of public participation in democratic processes.

A new EAN paper published in the European Journal of Neurology presents a roadmap toward reducing the burden imposed on patients, caregivers, and society by neurological diseases in Europe.

The Lancet Neurology highlights the urgent need to prioritise brain health in a new editorial, citing the Brain Health Mission as an example of positive initiatives aiming to promote brain health.  

Sebastiaan Engelborghs, Co-Chair of the EAN Scientific Panel on Dementia & Cognitive Disorders talks to EAN Communications Committee member Raphael Wurm about the recent decision by the European Medicines Agency to approve lecanemab for Alzheimer’s disease treatment.

The EAN welcomes the European Medicine Agency’s decision to approve lecanemab for the treatment of early Alzheimer's disease, which provides a much-needed treatment opportunity for this devastating condition.

Abstract submission and registration are NOW OPEN for the 11th Congress of the European Academy of Neurology!

The EAN has published a new e-book, showcasing the aims and achievements of the Brain Health Mission, titled 'Brain Health Mission: The Story So Far'.